Correlation of clinical outcomes with β-glucan levels in patients with invasive candidiasis
about
Empiric/pre-emptive anti-Candida therapy in non-neutropenic ICU patientsEMPIRICUS micafungin versus placebo during nosocomial sepsis in Candida multi-colonized ICU patients with multiple organ failures: study protocol for a randomized controlled trialProspective Evaluation of Serum β-Glucan Testing in Patients With Probable or Proven Fungal Diseases.Combined use of nonculture-based lab techniques in the diagnosis and management of critically ill patients with invasive fungal infections.Translational Development and Application of (1→3)-β-d-Glucan for Diagnosis and Therapeutic Monitoring of Invasive Mycoses.Serum 1,3-beta-d-glucan for antifungal treatment stratification at the intensive care unit and the influence of surgery.Comparison of Serum Galactomannan and 1,3-Beta-D-Glucan Determination for Early Detection of Invasive Pulmonary Aspergillosis in Critically Ill Patients with Hematological Malignancies and Septic Shock.Evaluation of serum (1 → 3)-β-D-glucan clinical performance: kinetic assessment, comparison with galactomannan and evaluation of confounding factors.β-D-Glucan and Candida albicans germ tube antibody in ICU patients with invasive candidiasis.Failure of empirical systemic antifungal therapy in mechanically ventilated critically ill patients.The serum glucan level and pathological changes of antifungal treatment for lower respiratory tract infection of Candida albicans.Why should we monitor (1-3)-β-D-glucan levels during invasive candidiasis? Just ask your ophthalmologist!Reply to "Why should we monitor (1-3)-β-D-glucan levels during invasive candidiasis? Just ask your ophthalmologist!".Short fungal fractions of β-1,3 glucans affect platelet activation.Use of 1,3-β-D-glucan in invasive fungal diseases in hematology patients.Experience with β-D-Glucan Assay in the Management of Critically ill Patients with High Risk of Invasive Candidiasis: An Observational Study.T2 Magnetic Resonance Assay: Overview of Available Data and Clinical Implications.
P2860
Q26852351-7B1CC35C-51B5-4970-85AB-A1B6F7421208Q34465297-08F3FF1C-3376-4425-A8C1-91C85228E616Q37089475-23736950-6F4C-48E7-8E95-200DB502DE11Q38067507-6D0781BE-C11F-4154-BA9A-90A4601DAF1CQ38679742-AA42F4CD-4BAF-4812-8590-2D4B1C7286D3Q39367519-D2ECA32A-76BD-4093-9D9F-42BEAAF53B1EQ40688927-81F849AA-6D66-4F07-B91D-2057C72E81ADQ40948260-73E3B898-F3A8-49BA-B02E-D9996005C312Q41128217-3B171EDA-0CC7-4690-B04D-AF0654BA7DFDQ41204913-30C6FFC4-06C4-4A20-8D20-3418593E49DFQ41570426-9C968958-2EF2-4178-BB5D-CE85A7CC9FA8Q43170963-A8F22947-684C-49B7-95BB-C37298ACEFA6Q43170968-D5C69124-BA59-4AA0-90E3-D30562647E4FQ43945201-C8EA1E9E-092F-4EFE-BDC5-E44E5E92F4F2Q50072321-612A5C4F-C764-4CDC-A327-5F55DB56A5F0Q55105395-DD1374F8-9EE1-40D1-B1C6-1EFB46CC19F2Q55437393-B16AFA34-A35A-41E2-9D80-E76DA04DADA8
P2860
Correlation of clinical outcomes with β-glucan levels in patients with invasive candidiasis
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Correlation of clinical outcom ...... ents with invasive candidiasis
@ast
Correlation of clinical outcom ...... ents with invasive candidiasis
@en
type
label
Correlation of clinical outcom ...... ents with invasive candidiasis
@ast
Correlation of clinical outcom ...... ents with invasive candidiasis
@en
prefLabel
Correlation of clinical outcom ...... ents with invasive candidiasis
@ast
Correlation of clinical outcom ...... ents with invasive candidiasis
@en
P2093
P2860
P356
P1476
Correlation of clinical outcom ...... ents with invasive candidiasis
@en
P2093
Charles R Sims
Jose Rodriguez
Luis Ostrosky-Zeichner
Malcolm Finkelman
Siraya Jaijakul
P2860
P304
P356
10.1128/JCM.00773-12
P407
P577
2012-03-29T00:00:00Z